We are a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with our novel, proprietary, catheter-based Ultra-Low Temperature Ablation ( ULTA ) technology, formerly known as Ultra-Low Temperature Cryoablation ( ULTC ) technology. VT is a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart s lower cham…
Negative free cash flow of -$19M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
Net Income (TTM)
-$24M
Op. Margin
—
ROIC
-55.37%
Cash Flow & Balance Sheet
FCF (TTM)
-$16M
Op. Cash Flow (TTM)
-$16M
Net Debt
$11M
Cash & Equiv.
$13M
Continue Research